Wed.Nov 22, 2023

article thumbnail

To address shortage, Novo Nordisk will cut production of Victoza to boost supply of Ozempic

Fierce Pharma

Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing production of diabetes drug Victo | Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing production of diabetes drug Victoza to make more Ozempic.

article thumbnail

Sunnyside Secures $11.5M To Help People Build Healthier Drinking Habits

MedCity News

Sunnyside, which offers an app to help consumers moderate their drinking, has raised $11.5 million in Series A funding. The round was led by Motley Fool Ventures and will be partially used for product development.

113
113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pfizer's cost-savings mission continues with office shuffle, job cuts in Ireland

Fierce Pharma

Pfizer, working through a $3.5 billion cost-cutting drive, is not done yet making changes to its workforce in Ireland. | Pfizer's commercial office in Citywest, Dublin, will move to its Ringsend office building, the Irish Independent reports. The moves could end in more job cuts in the company's commercial division.

309
309
article thumbnail

Mayo Clinic, Ayble Health Team Up Make GI Care Less Complicated

MedCity News

Digital health platform Ayble Health partnered with Mayo Clinic to offer patients a hybrid care model for digestive health that matches them with the appropriate virtual and in-person services based on their acuity and needs. The hybrid care model is available for large employers and health plans.

Patients 111
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz, other generic players

Fierce Pharma

Looking to protect its lucrative immunology drug Rinvoq, AbbVie is suing a clutch of generic drug makers that are attempting to market copycat versions of the blockbuster. | In a lawsuit filed in Delaware federal court Monday, AbbVie accused Sandoz, Hetero Labs, Aurobindo Pharma, Intas Pharmaceuticals and Sun Pharmaceutical of trying to sidestep dozens of patents protecting Rinvoq through the next decade.

Pharma 263
article thumbnail

Recognizing and Respecting Tech’s Influence on Process and Culture in Healthcare

MedCity News

Simply put, there’s no turning back from the digital transformation that’s underway and continuing to pick up steam. This is why it’s critical for the people who design and use healthcare technology to always consider the influence it can have.

More Trending

article thumbnail

Evelo Bio Shutdown Follows a Series of Microbiome Therapy Trial Failures

MedCity News

Evelo Biosciences’ vision of using microbes to engage the gut and modulate immune responses remains unrealized. With financing prospects dim and no one willing to take on its assets, Evelo is dissolving its business.

article thumbnail

Eli Lilly supports Alto Neuroscience in $45m Series C round

Pharmaceutical Technology

The funding will go towards the development of the company's four CNS candidates, with Phase II study data readouts expected by early 2025.

116
116
article thumbnail

It’s Time for the Tech Revolution to Come to Mental Health Diagnoses

MedCity News

We need to take inspiration from the progress in oncology over the last few decades and challenge ourselves to adapt its successful playbook to mental illness. It’s time for precision psychiatry.

Medical 107
article thumbnail

Signal: Moderna mRNA patent revoked by EPO after Pfizer suit

Pharmaceutical Technology

Pfizer and BioNTech countersued Moderna following an initial August 2022 suit alleging that its patents were overly broad.

111
111
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

White Bagging Policies Endanger the Lives of Cancer Patients

MedCity News

Insurers and PBMs are increasingly implementing white-bagging policies, which require oncology practices to obtain physician-administered infusions and other medications from designated specialty pharmacies often owned by or affiliated with insurers and their PBMs.

Insurance 103
article thumbnail

Investigating Industry Involvement in Modern Clinical Trials

Pharmaceutical Commerce

Study aims to find ways industry gets involved in the most influential clinical trials, and how transparent these trials are.

105
105
article thumbnail

Specialty Medication Enrollment: Going Digital Is Not Going Far Enough

MedCity News

Innovations in healthcare and technology are reshaping the specialty pharmacy onboarding process. Embracing digital technologies, connected ecosystems, automation, and longitudinal reporting can eliminate paperwork, accelerate processes and provide data-driven insights for continuous improvement.

Medical 96
article thumbnail

EC approves first-line ovarian cancer treatment

European Pharmaceutical Review

The European Commission (EC) has authorised a Type II variation for the poly (ADP-ribose) polymerase (PARP) inhibitor Rubraca ® (rucaparib). The small molecule treatment is indicated as a first-line maintenance treatment for individuals with advanced ovarian cancer regardless of their BRCA mutation status, who have responded to first-line platinum-based chemotherapy.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

PREDICTOM trial backed by €21m for early Alzheimer’s detection

PharmaTimes

The trial will use an AI screening platform to identify those most at risk of dementia - News - PharmaTimes

103
103
article thumbnail

Genentech and NVIDIA enter generative AI-powered drug discovery deal

Pharmaceutical Technology

Genentech has entered a research partnership with NVIDIA to expedite the discovery and development of new drugs.

98
article thumbnail

Thousands of men to participate in UK trial for prostate cancer

PharmaTimes

Prostate cancer is responsible for 12,000 deaths every year in the UK - News - PharmaTimes

105
105
article thumbnail

US Senate Committee calls pharma giants for another hearing on drug pricing

Pharmaceutical Technology

A US senate committee scheduled a hearing on prescription drug pricing with major pharmaceutical companies.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Blow to Moderna as EU nixes mRNA vaccine patent

pharmaphorum

Blow to Moderna as EU nixes mRNA vaccine patent Phil.

103
103
article thumbnail

IGC Pharma signs agreement to adopt AI solutions into drug discovery

Pharmaceutical Technology

IGC Pharma has entered into an agreement with the University of Los Andes, Colombia, to adopt generative AI solutions for drug development.

Pharma 64
article thumbnail

Boehringer buys cancer immunotherapy firm T3 for $507m

pharmaphorum

Boehringer buys cancer immunotherapy firm T3 for $507m Phil.

94
article thumbnail

The Role of Medical Directories in Streamlining New Drug Introductions

Scott’s Directories

In the massive and ever-growing healthcare industry, the accessibility of accurate and comprehensive medical information is not just a convenience—it’s a necessity. As healthcare professionals navigate the complexities of patient care, research, and pharmaceutical advancements, the demand for reliable resources has never been higher. One such important aspect is new drug introductions.

Medical 52
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Boosting Sales Rep Performance: The Role of Gamification in Productivity Tools

Toolyt

In the fast-paced world of sales, staying ahead of the competition requires not only a skilled sales team but also innovative tools that can drive productivity and performance. One such tool that has gained prominence in recent years is gamification integrated into productivity tools. This strategy, often overlooked, has proven to be a game-changer in motivating and enhancing the performance of sales representatives.

Sales 52
article thumbnail

Drug Digest: The Shape of Things to Come: Advances and Improvements in Excipients

PharmaTech

In this episode of Drug Digest, Pharmaceutical Technology’s European/Senior Editor, Felicity Thomas, chats about the biggest trends impacting oral and topical drug delivery and how these trends are impacting the excipient sector with Nick DiFranco and Ashley Rezak from Lubrizol Life Science Health.

article thumbnail

Do healthcare mergers and acquisitions lead to better care for patients?

Clarify Health

Today’s healthcare providers are seeing significantly more patients than they did a decade ago – many of whom are often sicker and have more complex care needs. This increase can be attributed to many things, including an aging population, the increasing prevalence of chronic conditions, and greater access to care stemming from expanded insurance coverage.

Leads 52
article thumbnail

Concerns voiced as Palantir wins £330m NHS data contract

pharmaphorum

Concerns voiced as Palantir wins £330m NHS data contract Phil.

85
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Organon’s chief medical officer wants to change how the world sees women’s health

PharmaVoice

Dr. Juan Camilo Arjona Ferreira joined Organon in September and says the company is “like a lighthouse in women’s health” in its visibility and focus.

Medical 52
article thumbnail

Piloting New Drug Development: Q&A With Dr. Bruce Leuchter, Ceo of Neurvati

PharmExec

Leuchter discusses FDA’s new pilot program.

94
article thumbnail

Expert Discusses Biosimiliars Influencing Pricing of Biologic Drugs

Pharmacy Times

Denise Giambalvo, director of Member Engagement & Business Strategy at the Washington Health Alliance and recently led a biosimilars initiative for the coalition, discusses biosimilar influence of pricing for biologic drugs, trends to expect in 2024, and why education on biosimilars are important for patients, pharmacists, prescribers, and more

article thumbnail

UK's Autumn Budget welcomed by pharma trade organisations

pharmaphorum

UK's Autumn Budget welcomed by pharma trade organisations Phil.

Pharma 78
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.